Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday

Ball Corporation Common Stock -1.32% Post
Cytokinetics, Incorporated +1.47% Post
Freshworks +1.17% Post
Karuna Therapeutics 0.00% Post
Microsoft Corporation +0.23% Post

Ball Corporation Common Stock

BALL

63.77

63.77

-1.32%

0.00% Post

Cytokinetics, Incorporated

CYTK

69.00

69.00

+1.47%

0.00% Post

Freshworks

FRSH

17.30

17.30

+1.17%

0.00% Post

Karuna Therapeutics

KRTX

329.83

329.83

0.00%

0.00% Post

Microsoft Corporation

MSFT

414.58

414.60

+0.23%

0.00% Post

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Keybanc raised Netflix, Inc. (NASDAQ:NFLX) price target from $510 to $525. Keybanc analyst Justin Patterson maintained an Overweight rating. Netflix shares gained 0.1% to close at $491.79 on Wednesday. See how other analysts view this stock.
  • JP Morgan boosted the price target for Karuna Therapeutics, Inc. (NASDAQ:KRTX) from $217 to $330. JP Morgan analyst Jessica Fye downgraded the stock from Overweight to Neutral. Karuna Therapeutics shares gained 0.1% to close at $317.16 on Wednesday. See how other analysts view this stock.
  • Canaccord Genuity boosted the price target for MicroStrategy Incorporated (NASDAQ:MSTR) from $670 to $791. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. MicroStrategy shares gained 11.1% to close at $670.71 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. increased Zevra Therapeutics, Inc. (NASDAQ:ZVRA) price target from $10 to $15. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Zevra Therapeutics shares gained 10.7% to close at $5.48 on Wednesday. See how other analysts view this stock.
  • Needham boosted the price target for Freshworks Inc. (NASDAQ:FRSH) from $25 to $30. Needham analyst Scott Berg maintained a Buy rating. Freshworks shares fell 0.5% to close at $23.73 on Wednesday. See how other analysts view this stock.
  • Mizuho increased the price target for Ball Corporation (NYSE:BALL) from $60 to $62. Mizuho analyst John Roberts maintained a Neutral rating. Ball shares rose 0.5% to close at $57.91 on Wednesday. See how other analysts view this stock.
  • Truist Securities raised NIKE, Inc. (NYSE:NKE) price target from $107 to $111. Truist Securities analyst Beth Reed maintained a Hold rating. NIKE shares fell 0.8% to close at $107.13 on Wednesday. See how other analysts view this stock.
  • Benchmark boosted Nova Ltd. (NASDAQ:NVMI) price target from $125 to $150. Benchmark analyst Mark Miller maintained a Buy rating. Nova shares fell 0.6% to close at $135.18 on Wednesday. See how other analysts view this stock.
  • Wedbush boosted Microsoft Corporation (NASDAQ:MSFT) price target from $425 to $450. Wedbush analyst Daniel Ives maintained an Outperform rating. Microsoft shares fell 0.2% to close at $374.07 on Wednesday. See how other analysts view this stock.
  • Raymond James increased Cytokinetics, Incorporated (NASDAQ:CYTK) price target from $63 to $92. Raymond James analyst Sean McCutcheon maintained an Outperform rating. Cytokinetics shares jumped 82.5% to close at $83.44 on Wednesday. See how other analysts view this stock.

 

Check This Out: Hershey, Levi Strauss And 2 Other Stocks Insiders Are Selling

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via